SLUP yields 20000000.00% · JNJ yields 2.13%● Live data
📍 SLUP pulled ahead of the other in Year 1
Combined, SLUP + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SLUP + JNJ for your $10,000?
Solucorp Industries, Ltd., together with its subsidiaries, develops and markets metal remediation technologies and solutions for the protection of families, communities, and the environment. It offers Molecular Bonding System technology that remediates various metal contaminants in mediums, including soil, sludge, slag, sediment, baghouse dust, and flyash; develops and promotes Integrated Fixation Systems (IFS) RE-ME-DI-ATE products that prevent pollution at source, as well as protects families and environment from toxic heavy metal contaminants; and holds patents for an Electrocoagulation technology for the treatment of wastewater and other aqueous waste streams by using electrical currents that de-stabilize currents suspended emulsified or dissolved contaminants. The company's IFS technology is also used in making ammunition to prevent future lead contamination at gun ranges and military installations. Solucorp Industries, Ltd. was formerly known as World Tec Industries Inc. Solucorp Industries, Ltd. was founded in 1987 and is based in Orangeburg, New York.
Full SLUP Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.